PubRank

Transcatheter aortic valve replacement and standard therapy in inoperable patients with aortic stenosis and low EF.

PubWeight™: 1.42‹?› | Rank: Top 5%

🔗 View Article (PMID 25586156)

Published in Heart on January 13, 2015

Authors

Jonathan J Passeri1, Sammy Elmariah2, Ke Xu3, Ignacio Inglessis1, Joshua N Baker4, Maria Alu3, Susheel Kodali3, Martin B Leon3, Lars G Svensson5, Philippe Pibarot6, William F Fearon7, Ajay J Kirtane3, Gus J Vlahakes4, Igor F Palacios1, Pamela S Douglas8, PARTNER Investigators

Author Affiliations

1: Cardiology Division, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
2: Cardiology Division, Department of Medicine, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA Harvard Clinical Research Institute, Boston, Massachusetts, USA.
3: Columbia University Medical Center/New York-Presbyterian Hospital, The Cardiovascular Research Foundation, New York, New York, USA.
4: Department of Cardiac Surgery, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
5: Department of Cardiovascular Medicine, Cleveland Clinic, Cleveland, Ohio, USA.
6: Québec Heart and Lung Institute, Laval University, Québec, Canada.
7: Stanford University School of Medicine, Stanford, California, USA.
8: Duke Clinical Research Institute/Duke University Medical Center, Durham, North Carolina, USA.

Associated clinical trials:

THE PARTNER TRIAL: Placement of AoRTic TraNscathetER Valve Trial (PARTNER) | NCT00530894

Predictors Of Left Ventricular Systolic Function Recovery After Transcatheter Aortic Valve Replacement | NCT05069168

Articles citing this ↘

The role of TTE in assessment of the patient before and following TAVI for AS. Echo Res Pract (2016) 1.01

Interventional cardiology: TAVR improves survival in inoperable patients with severe aortic stenosis. Nat Rev Cardiol (2015) 0.75

Impact of Ejection Fraction and Aortic Valve Gradient on Outcomes of Transcatheter Aortic Valve Replacement. J Am Coll Cardiol (2016) 0.75

Articles by these authors ⇆

Cost-effectiveness of transcatheter aortic valve replacement compared with standard care among inoperable patients with severe aortic stenosis: results from the placement of aortic transcatheter valves (PARTNER) trial (Cohort B). Circulation (2012) 2.71

Cost-effectiveness of transcatheter aortic valve replacement compared with surgical aortic valve replacement in high-risk patients with severe aortic stenosis: results of the PARTNER (Placement of Aortic Transcatheter Valves) trial (Cohort A). J Am Coll Cardiol (2012) 2.56

Costs of periprocedural complications in patients treated with transcatheter aortic valve replacement: results from the Placement of Aortic Transcatheter Valve trial. Circ Cardiovasc Interv (2014) 1.49

Outcomes of transcatheter and surgical aortic valve replacement in high-risk patients with aortic stenosis and left ventricular dysfunction: results from the Placement of Aortic Transcatheter Valves (PARTNER) trial (cohort A). Circ Cardiovasc Interv (2013) 1.48

Mitral valve-in-valve hemodynamic performance: An in vitro study. J Thorac Cardiovasc Surg (2015) 1.38

Predictors of poor outcomes after transcatheter aortic valve replacement: results from the PARTNER (Placement of Aortic Transcatheter Valve) trial. Circulation (2014) 1.34

One-Year Clinical Outcomes With SAPIEN 3 Transcatheter Aortic Valve Replacement in High-Risk and Inoperable Patients With Severe Aortic Stenosis. Circulation (2016) 0.88

Temporal Trends in Quality of Life Outcomes After Transapical Transcatheter Aortic Valve Replacement: A Placement of AoRTic TraNscathetER Valve (PARTNER) Trial Substudy. Circ Cardiovasc Qual Outcomes (2015) 0.75

Trends in Utilization of Aortic Valve Replacement for Severe Aortic Stenosis. J Am Coll Cardiol (2022) 0.75

Are the Current Doppler Echocardiography Criteria Able to Discriminate Mitral Bileaflet Mechanical Heart Valve Malfunction? An In Vitro Study. Artif Organs (2016) 0.75